Results 111 to 120 of about 20,825 (172)

Applying convergent parallel mixed methods design to investigate medication adherence among people living with HIV in resource-limited settings: methodological insights from Ghana. [PDF]

Front Public Health
Dzramado VL, Oduro E, Lasim OU.
europepmc   +1 more source

Nanoparticles in HIV treatment for improved drug delivery, clinical translation, and future direction. [PDF]

Discov Nano
Terkimbi SD, Dangana RS, Mbina SA, Paul-Chima UO, Aja PM, Mujinya R.   +5 more
europepmc   +1 more source

Viral suppression and adverse events following antiretroviral therapy optimization among children and adolescents in Uganda, 2018-2023. [PDF]

BMC Public Health
Ankunda C, Namasambi S, Kyomuhangi B, Emunyu J, Sserunjogi C, Nakaweesi J.   +5 more
europepmc   +1 more source

Persistent Seronegativity and Absence of Intact Proviruses Despite Prolonged Initial Viremia in Early-Treated Perinatal HIV Infection. [PDF]

Open Forum Infect Dis
Charre C, Buseyne F, Mélard A, Gardiennet E, Mariaggi AA, Montange T, Le Chenadec J, Warszawski J, Blanche S, Avettand-Fenoël V, Frange P.   +10 more
europepmc   +1 more source

Assessing the preparedness of primary healthcare facilities for the implementation of universal test and treat in uThukela District, South Africa: a cross-sectional study. [PDF]

BMJ Public Health
Turawa E, Basera W, Hlongwa M, Mathole T, Bradshaw D, Nicol E.   +5 more
europepmc   +1 more source

Neonatal mortality attributable to preterm births associated with maternal HIV infection in sub-Saharan Africa. [PDF]

AIDS
Nchinda N, Hemelaar J.
europepmc   +1 more source

Baseline characteristics associated with mortality among children living with HIV initiating ART at a rural district HIV clinic of Mozambique. [PDF]

Sci Rep
Nacarapa E, Maddalozzo R, Moosa MS, Abecasis A.   +3 more
europepmc   +1 more source

Kidney Dysfunction In Young People Living With HIV On Dolutegravir-Based Regimens In Kampala, Uganda

Nasuuna EM, Hoffman R, Kalyesubula R, Chikwari CD, Weiss HA.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Metabolism of zidovudine

General Pharmacology: The Vascular System, 1995
1. The anti-HIV drug zidovudine (3'-azido-2',3'-dideoxythymidine; ZDV) has three important pathways of metabolism. ZDV is a prodrug and must be phosphorylated in lymphocytes in order to exert its antiviral action. However, in quantitative terms this is a minor pathway probably accounting for less than 1% of the overall metabolic profile.
G J, Veal, D J, Back
openaire   +2 more sources